Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 1, 2000, Pages 45-49

  Ogretmen, Besim ^a   Barredo, Julio C ^a,b   Safa, Ahmad R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Childhood ALL; LRP; MDR1; MRP; Multidrug resistance

Indexed keywords

LUNG RESISTANCE PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNOPHENOTYPING; INFANT; MALE; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADOLESCENT; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HL-60 CELLS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RNA, MESSENGER; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0034456382     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200001000-00009     Document Type: Article

References (18)

1. Stammler G, Sauerbrey A, Volm M. Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia. Cancer Lett 1995; 89: 129-35.
2. Den Boer ML, Zwaan CM, Pieters R, et al. Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia 1997; 11: 1078-85.
3. Safa AR. Multidrug resistance, in Schilsky R, Ratain MJ, Milano G (eds): Principles of antineoplastic drug development and pharmacology. New York, Marcel Dekker, Inc., 1996, pp 457-86.
4. Loe DW, Deeley RG, Cole SPC. Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 1996; 32A: 945-57.
5. Jedlitschky G, Leier I, Buchholz U, et al. Transport of glutathione, glucuronate and sulfate conjugates by MRP gene-encoded conjugate export pump. Cancer Res 1996; 56: 988-94.
6. Zaman GJR, Lankelma J, van Telligen O, et al. Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc Natl Acad Sci USA 1995; 92: 7690-4.
7. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1475-9.
8. Hart SM, Ganeshaguru K, Scheper RJ, et al. Expression of the human vault protein LRP in acute myeloid leukemia. Exp Hematol 1997; 25: 1227-32.
9. Pieters R, Kaspers GJL, van Wering ER, et al. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. Leukemia 1993; 7: 392-7.
10. McGrath T, Latoud C, Arnold ST, et al. Mechanisms of multidrug resistance in HL60 cells: Analysis of resistance associated membrane proteins and levels of MDR gene expression. Biochem Pharmacol 1989; 38: 3611-9.
11. Ogretmen B, Safa AR. Mini-preparation of total RNA for RT-PCR from cultured human cells. BioTechniques 1995; 19: 374-5.
12. Slovak ML, Ho PJ, Cole SPC, et al. LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: Evidence that chromosome breakage plays a key role in MRP and LRP gene amplification. Cancer Res 1995; 55: 4214-9.
13. Schneider E, Cowan K, Bader H, et al. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 1995; 85: 186-93.
14. Beck J, Handgretinger R, Dopfer R, et al. Expression of MDR-1, MRP, topoisomerase IIa/b, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Br J Haematol 1995; 89: 356-63.
15. Campos L, Oriol P, Sabido O, et al. Simultaneous expression of P-glycoprotein and bcl-2 in acute myeloid leukemia blast cells. Leuk Lymphoma 1997; 27: 119-25.
16. Sauerbrey A, Zintl F, Volm M. P-glycoprotein and glutathione S-transferase Pi in childhood acute lymphoblastic leukaemia. Br J Cancer 1994; 70: 1144-9.
17. Den Boer ML, Pieters R, Kazemier KM, et al. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression and drug resistance in childhood leukemia. Blood 1998; 91: 2092-8.
18. Beck WT, Grogan TM, Willman CL, et al. Methods to detect P-glycoprotein associated multidrug resistance in patients’ tumors: Consensus recommendations. Cancer Res 1996; 56: 3010-20.